Milan, Italy

Salvatore Pece

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Salvatore Pece: Innovator in Breast Cancer Stratification

Introduction

Salvatore Pece is a notable inventor based in Milan, Italy, recognized for his contributions to the field of oncology. With a total of three patents to his name, Pece has dedicated his research efforts to developing innovative methods and tools that enhance the understanding of breast cancer patient prognosis and treatment.

Latest Patents

Pece's latest patents focus on refined prognostic clinical tools, methods, and kits designed for evaluating the risk and treatment of distant recurrence in ER+/HER2− breast cancer patients. These inventions, titled "Methods and kits comprising gene signatures for stratifying breast cancer patients," represent a significant advancement in personalized medicine, aiming to improve treatment outcomes by better stratifying patients based on genetic signatures.

Career Highlights

Throughout his career, Salvatore Pece has made impactful strides in oncological research. He has worked with esteemed institutions such as the Istituto Europeo di Oncologia S.r.l. and the Fondazione Istituto Firc di Oncologia Molecolare (IFOM), contributing to advancements in cancer research and patient care.

Collaborations

Pece has collaborated with several prominent figures in his field, including Pier Paolo Di Fiore and Manuela Vecchi. These partnerships have fostered innovative research opportunities and have played a crucial role in the development of his patented technologies.

Conclusion

Salvatore Pece stands out as a visionary inventor in the realm of cancer research, particularly in the stratification of breast cancer patients. His work continues to play a pivotal role in enhancing clinical practices and improving patient outcomes through innovative medical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…